Company Overview of Cantabria Pharma S. L.
Cantabria Pharma S.L. operates as a generics formulation company in Spain. It focuses on various therapeutic areas, including psychiatry/CNS, respiratory, ENT, orthopedic, pain management, rheumatology, and pediatrics. The company markets patented molecules through in-licensing from various pharmaceutical companies. It serves doctors. The company was founded in 1997 and is based in Madrid, Spain. As of October 17, 2006, Cantabria Pharma S.L. operates as a subsidiary of Wanbury Ltd.
Calle Arequipa 1
Founded in 1997
34 91 382 29 90
34 91 381 79 10
Key Executives for Cantabria Pharma S. L.
Cantabria Pharma S. L. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Ability Pharmaceuticals, S.L.||Europe|
|Activery Biotech SL||Europe|
|Aelix Therapeutics SL||Europe|
|AlbaJuna Therapeutics SL||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cantabria Pharma S. L., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.